Sign in

CIK 0001570562

  • Accelerated filer

Evolus, Inc.

Sign in to watch
Ticker
EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
461385614
Phone
+1 949-284-4555
Business address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
Former names
Evolus, Inc.
  1. 4 Open-market sale SILVERNAIL LAUREN P sold 2,612 shares at $13.53 ($35,352)
  2. 4 Open-market buy Director bought 40,562 shares at $19.25 ($780,819)
  3. 4 Open-market buy Director bought 628,536 shares at $19.25 ($12,099,318)
  4. 4 Open-market sale 10% owner sold 5,307,940 shares at $19.25 ($102,177,845)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market buy Director bought 16,000 shares at an average $12.58 ($201,204)
  16. 4 Open-market buy Director bought 3,000 shares at $12.77 ($38,300)
  17. 4 Open-market buy Director bought 7,800 shares at $13.04 ($101,689)
  18. 4 Open-market buy Director bought 295,024 shares at $14.00 ($4,130,336)
  19. 4 Open-market buy Director bought 6,347 shares at $14.00 ($88,858)
  20. 4 Open-market sale 10% owner sold 573,888 shares at $14.00 ($8,034,432)

Page 11 of 13 · 252 filings